UNSPSC 51241301: Aluminum acetate

This classification denotes an astringent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80EHD8I43D. European Medicines Agency schedules Aluminium acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12809MIG. Aluminum acetate generally arises in the molecular formula 3C2H3O2.AL. The term 'aluminum acetate' is a U.S. Pharmacopeial Convention designation. As of Q4 2014, ALUMINUM ACETATE remains the US FDA Preferred Term for this commodity.

Aluminum acetate bears US NLM identifiers UMLS ID C0051510 and NCI Concept Code C47387. SMILES: CC(=O)O[AL]OC(=O)C.O.

UNSPSC 51241301 Aluminum acetate is a Commodity code that nominally covers specialized chemical compounds, but recent state and local solicitations show minimal direct activity under this specific code. Instead, municipal water treatment and healthcare purchasing have issued bids for chemically related products — sodium bisulfite for water pollution control and pharmaceuticals through cooperative purchasing — that diverge substantially from the narrow aluminum acetate designation. The actual procurement activity under this code appears to reflect chemical supply to public utilities and health systems rather than aluminum acetate specifically.

State and local governments soliciting under or near this code include municipal water authorities and multi-state cooperative purchasing alliances. The City of Meriden, Connecticut issued an IFB (B027-15) for sodium bisulfite chemical supply to its Water Pollution Control Facility, due July 29, 2026, requiring performance and payment bonds along with substantial insurance coverage including $1,000,000 to $2,000,000 general liability. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in multiple states including Oregon, with proposals due March 26, 2026 and awards effective July 1, 2026. MMCAP's framework requires vendors to work through three authorized wholesalers and certify cGMP and Drug Supply Chain Security Act compliance. The geographic spread remains limited to visible recent activity in Connecticut and the MMCAP multi-state region; broader activity under the aluminum acetate code itself is not evident in the recent opportunity set.